[ad_1]
June 28, 2018
Obtained good results in mice, monkeys and guinea pigs
Illustrative image: Pixabay
Late 2019, the vaccine to cure the human immunodeficiency virus (HIV ) will be tested in humans after giving good results. results by neutralizing several strains of HIV in animals.
The study published June 4 in the scientific journal Natura, conducted by researchers at the US National Institute of Allergy and Infectious Diseases, reports that the new experimental vaccine, designed to attacking certain vulnerable regions of the HIV strain To generate antibodies in tests on mice, guinea pigs and monkeys, dozens of HIV strains have been neutralized.
Because favorable results have been obtained, medical researchers believe that the vaccine is ready to be tested in humans, and for the second half of 2019, meanwhile, doctors are practicing it. other techniques to increase their potency and effectiveness to achieve better results.
They also explained that the procedure was to identify antibodies capable of neutralizing HIV strains. The second step was to obtain these antibodies by immunization based on the structure of the surface protein of the disease to which they are attached to increase their effectiveness.
This vaccine is one of the most recent and effective broad-spectrum attempts to protect and neutralize a large number of HIV strains, according to Milenio.
[ad_2]
Source link
